CSCO

Cisco Systems, Inc. - 10-Q Summary (Quarter Ended Jan 27, 2007)

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended January 27, 2007 (Fiscal Q2 2007) and the six months ended January 27, 2007. Cisco Systems, Inc. designs, manufactures, and sells networking products and services globally. A significant business event during this period was the full integration of the Scientific-Atlanta acquisition (completed Feb 2006), which contributed $639 million in net sales for the quarter and $1.2 billion for the six-month period. The company operates across five geographic theaters: United States and Canada, European Markets, Emerging Markets, Asia Pacific, and Japan.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 27.3% year-over-year for the quarter and 26.1% for the six-month period. Product sales grew 28.2% (quarter) and 27.3% (six months), while service sales grew 22.8% and 20.2%, respectively.
• Margin Compression: Gross margin percentage decreased from 67.4% in the prior year quarter to 63.8% in the current quarter. This decline is primarily attributed to the inclusion of Scientific-Atlanta, which has a lower gross margin profile, as well as sales discounts and product mix changes.
• Operating Expenses: Total operating expenses increased 19.1% year-over-year for the quarter, driven by investments in sales and engineering headcount and expenses related to the Scientific-Atlanta acquisition. However, operating expenses as a percentage of revenue decreased.
• Tax Rate: The effective tax rate dropped significantly to 17.7% for the quarter (from 28.2% in the prior year) due to the reinstatement of the U.S. federal R&D tax credit and an increase in foreign income taxed at lower rates.
• Stock Repurchases: The company repurchased 187 million shares of common stock for $4.78 billion during the six-month period. As of Jan 27, 2007, $6.77 billion remained authorized under the repurchase program.

Guidance, Outlook, and Risks

Management Commentary: Management highlighted strong growth in "advanced technologies" (up 66% year-over-year), driven by video systems (Scientific-Atlanta), unified communications, security, and wireless. The company continues to focus on the commercial market, emerging markets, and next-generation service provider network build-outs. Inventory management remains a focus as the company implements a lean manufacturing model.

Risks and Contingencies:

• Legal Proceedings: Several patent infringement lawsuits are pending (e.g., QPSX/Ipernica, Telcordia, Forgent). Trials are scheduled for April and May 2007. Management believes damages are unlikely to be material but cannot estimate outcomes.
• Market Risks: Exposure to foreign currency fluctuations, interest rate changes (mitigated by $6.0 billion in interest rate swaps), and equity market volatility.
• Supply Chain: Risks related to component shortages, manufacturing capacity constraints, and the transition to lean manufacturing.
• Acquisition Integration: Risks associated with integrating Scientific-Atlanta and future acquisitions, including potential goodwill impairments.

Investor Verification Checklist

• Verify the sustainability of the 63.8% gross margin given the lower-margin mix from Scientific-Atlanta.
• Monitor the outcome of pending patent litigation trials scheduled for April and May 2007.
• Assess the impact of the $6.5 billion debt load on future interest expenses, particularly with the conversion of fixed rates to floating rates via swaps.
• Review inventory levels ($1.64 billion) and the effectiveness of the lean manufacturing implementation in preventing obsolescence.
• Confirm the continued growth trajectory of "advanced technologies" as a percentage of total product sales.